4.3 Review

A safety evaluation of pirfenidone for the treatment of idiopathic pulmonary fibrosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Effect of pirfenidone delivered using layer-by-layer thin film on excisional wound healing

Praveen Kumar Mandapalli et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)

Article Medicine, Research & Experimental

Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis

Marlies S. Wijsenbeek et al.

ADVANCES IN THERAPY (2015)

Article Multidisciplinary Sciences

Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

Carlos Aravena et al.

PLOS ONE (2015)

Review Medicine, Research & Experimental

Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events

Ulrich Costabel et al.

ADVANCES IN THERAPY (2014)

Article Medicine, General & Internal

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Cardiac & Cardiovascular Systems

Real world experiences: Pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis

Nazia Chaudhuri et al.

RESPIRATORY MEDICINE (2014)

Review Respiratory System

Pirfenidone: an update on clinical trial data and insights from everyday practice

Michael Kreuter

EUROPEAN RESPIRATORY REVIEW (2014)

Article Respiratory System

Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis

Toru Arai et al.

RESPIRATORY INVESTIGATION (2014)

Article Cardiac & Cardiovascular Systems

Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice

Ryo Okuda et al.

RESPIRATORY MEDICINE (2013)

Article Medicine, General & Internal

Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis

Ganesh Raghu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Critical Care Medicine

Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis

Roland M. du Bois et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Critical Care Medicine

An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Medicine, General & Internal

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Respiratory System

Pirfenidone in idiopathic pulmonary fibrosis

H. Taniguchi et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Article Pharmacology & Pharmacy

Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults

C. M. Rubino et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)

Article Ophthalmology

Effects of Pirfenidone on Proliferation, Migration, and Collagen Contraction of Human Tenon's Fibroblasts In Vitro

Xianchai Lin et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)

Article Critical Care Medicine

Molecular targets in pulmonary fibrosis - The myofibroblast in focus

Chris J. Scotton et al.

Article Gastroenterology & Hepatology

Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production

A Di Sario et al.

JOURNAL OF HEPATOLOGY (2002)